{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-025182","form_type":"8-K","ticker":"QSI","cik":"0001816431","company_name":"Quantum-Si Inc","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.307563+00:00","generated_at":"2026-06-02T06:46:11.807201+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Quantum-Si reports Q1 revenue $457K, net loss $19.5M; launches Platinum instrument","bullets":["Revenue of $457,000; gross profit $269K at 59% margin.","Net loss $19.5M (vs $23.6M Q1 2023); adjusted EBITDA -$20.5M.","Full commercial launch of Platinum instrument started end of March 2024.","Version 3 sequencing kit on track for launch by end of Q3 2024.","Paula Dowdy added to Board; FY2024 financial guidance reaffirmed."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-025182","json":"https://secwatch.observer/filing/0001140361-24-025182.json","markdown":"https://secwatch.observer/filing/0001140361-24-025182.md","text":"https://secwatch.observer/filing/0001140361-24-025182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816431/000114036124025182/0001140361-24-025182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816431/000114036124025182/ef20028707_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T06:46:11.807201+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ca64a875a6bca32c000a7f60ab71b9f707de9e62","claim":"Quantum-Si Inc reported first quarter ended March 31, 2024 results: revenue $457,000, net income -$19.5 million (net loss of $19.5 million). Guidance reaffirmed.","evidence_excerpt":"the “Company”), The Protein Sequencing Company TM , today announced financial results for the first quarter ended March 31, 2024. Press Release Highlights ● Reported revenue of $457,000 in the first quarter of 2024 ● Commenced its full commercial launch of its Platinum ® instrument at the end of March 2024 ● On track to launch version 3 of its sequencing kit,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036124025182/0001140361-24-025182-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$457,000"},{"label":"Net income","value":"-$19.5 million (net loss of $19.5 million)"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}